MORGAN STANLEY

Position in ELVN — Enliven Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in ELVN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$25,878,843

+$5,550,822 QoQ

Shares Held

509,928

-1.7% QoQ

Ownership

0.696%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#33

of 208 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. ELVN ranks #81 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,878,843	509,928	-1.7%	Shares	Defined	2026-08-13
2026-03-31	$20,328,021	518,572	+25.9%	Shares	Defined	2026-05-15
2025-12-31	$6,342,074	411,823	+59.4%	Shares	Defined	2026-05-27
2025-09-30	$5,289,118	258,384	+1.4%	Shares	Defined	2026-05-27
2025-06-30	$5,112,247	254,848	+213.4%	Shares	Defined	2025-08-15
2025-03-31	$1,600,276	81,315	-26.5%	Shares	Defined	2025-05-15
2024-12-31	$2,488,633	110,606	-18.3%	Shares	Defined	2025-05-15
2024-09-30	$3,458,292	135,407	+98.3%	Shares	Defined	2025-05-14
2024-06-30	$1,596,165	68,300	+8.2%	Shares	Defined	2025-05-14
2024-03-31	$1,109,873	63,097	-20.7%	Shares	Defined	2024-10-17
2023-12-31	$1,100,567	79,521	+134.1%	Shares	Defined	2024-08-16
2023-09-30	$464,027	33,970	+1.9%	Shares	Defined	2023-11-15
2023-06-30	$680,080	33,321	+91.3%	Shares	Defined	2023-08-14
2023-03-31	$381,453	17,418	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.